Luann Zerefa
Overview
Explore the profile of Luann Zerefa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peter R, Bidkar A, Bobba K, Zerefa L, Dasari C, Meher N, et al.
Sci Rep
. 2024 Aug;
14(1):19938.
PMID: 39198676
Radiopharmaceutical therapy using -emitting Ac is an emerging treatment for patients with advanced metastatic cancers. Measurement of the spatial dose distribution in organs and tumors is needed to inform treatment...
2.
Bidkar A, Zerefa L, Yadav S, VanBrocklin H, Flavell R
Theranostics
. 2024 May;
14(7):2969-2992.
PMID: 38773983
Targeted alpha particle therapy (TAT) has emerged as a promising strategy for the treatment of prostate cancer (PCa). Actinium-225 (Ac), a potent alpha-emitting radionuclide, may be incorporated into targeting vectors,...
3.
Wang Y, Buck A, Piel B, Zerefa L, Murugan N, Coherd C, et al.
Mol Cancer
. 2024 Mar;
23(1):56.
PMID: 38491381
One of the major hurdles that has hindered the success of chimeric antigen receptor (CAR) T cell therapies against solid tumors is on-target off-tumor (OTOT) toxicity due to sharing of...